We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cineworld Group Plc | LSE:CINE | London | Ordinary Share | GB00B15FWH70 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.381 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCINE
RNS Number : 1192P
Cineworld Group plc
14 November 2016
Released: 14 November 2016
Cineworld Group plc
Allotment and Issue of New Ordinary Shares
Further to the acquisition of five Empire cinemas from Cinema Holdings Limited ("CHL") announced on 12 August 2016, Cineworld Group plc ("Cineworld") today announces the allotment and issue of 1,916,058 new ordinary shares (the "New Ordinary Shares") of Cineworld to CHL as deferred consideration shares.
An application has been made to the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange's main market for listed securities. It is expected that admission will commence on 18 November 2016. The New Ordinary Shares will rank pari passu with all of Cineworld's existing ordinary shares of GBP0.01 each.
For further details please contact:
Fiona Smith, Company Secretary, Cineworld Group plc, 020 8987 5000
Elly Williamson, Bell Pottinger, 020 3772 2573
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOEUSSURNUAAAAA
(END) Dow Jones Newswires
November 14, 2016 07:45 ET (12:45 GMT)
1 Year Cineworld Chart |
1 Month Cineworld Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions